All lobbying filings

ZIMMER BIOMET, INC.

ZIMMER BIOMET, INC. filed a Q3 report for ZIMMER BIOMET, INC. on October 16, 2026.

Lobbying for ZIMMER BIOMET, INC.

All filings by ZIMMER BIOMET, INC. · Everything ZIMMER BIOMET, INC. has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 16, 2026

Expenses

$180,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 7

Medicare/Medicaid

Artificial Intelligence and Machine Learning regulation and Medicare payment; Medicare Coverage of Innovative Medical Device; Medicare Physician Payment; Medicare Ambulatory Surgery Center and Hospital Outpatient Payment;

Trade (domestic/foreign)

Trade Issues/Policy

Taxation/Internal Revenue Code

Tax Issues;

Chemicals/Chemical Industry

EPA Regulations of Ethylene Oxide Sterilization of Medical Devices; EPA Regulations of PFAS

Medical/Disease Research/Clinical Labs

Breakthrough devices- H.R. 5343;

Science/Technology

e-labeling;

Manufacturing

issues related to Right to Repair

Bills named in this filing 1

H.R. 5343
Ensuring Patient Access to Critical Breakthrough Products Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.